Originally Posted by NamastePlatypus
ANyone have a link or info on still births and the vax.
There isn't any evidence of an increase, but there's not much evidence, period.
Here's a study that goes over what evidence exists :http://www.i-lumens.com/DOCUMENTS/VA...CET%202008.pdf
(this is the study the CDC cites to say "there is no evidence vaxing pregnant women is associated with anything bad")
|No serious adverse eff ects of infl uenza immunisation
in pregnancy have been reported in the few published
studies on vaccine safety. There are, however, limited
data on safety in the fi rst trimester.
|Consideration should be given to developing
mechanisms for following up pregnancy outcomes after
maternal immunisation to augment passive surveillance,
particularly if national recommendations are broadened
for this group.
Ok...so let's hop over to the new analysis of the safety of the pandemic vax:http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5848a4.htm
So, they're analysing info from VAERS and the VSD.
|The remaining 173 nonfatal serious adverse events after vaccination with H1N1 vaccines are under chart review. These reports fall into the following diagnostic categories: neurologic or muscular condition other than Guillain-Barré syndrome (49 [28%]); pneumonia or influenza-like illness (27 [16%]); other noninfectious conditions, including multiple medical symptoms (19 [11%]); respiratory or ear, nose, and throat condition (17 [10%]); allergic conditions other than anaphylaxis (16 [9%]); pregnancy complications** (15 [9%]); other infectious symptoms (10 [6%]); gastrointestinal (eight [5%]); cardiovascular (six [3%]); and psychiatric (six [3%]). Each category includes a variety of diagnoses; no patterns were identified.
They clarify "pregnancy complications" as:
|** Stillbirth, spontaneous abortion, or preterm delivery.
So what do they say the VSD says about "pregnancy complications"?
|VSD is a collaboration between CDC and eight managed-care organizations with a total of 9.5 million members, which utilizes administrative data and electronic medical records to collect information on vaccinations and health-care encounters to monitor vaccine safety. VSD is monitoring H1N1 vaccine safety using historical and other appropriate comparison groups, with weekly data analyses (4). As of November 21, 438,376 doses of H1N1 vaccines (323,345 MIV and 115,031 LAMV) had been administered to patients under VSD surveillance. During October 1--November 21, no cases of Guillain-Barré syndrome and one case of anaphylaxis were observed among vaccinated persons in VSD. In addition, VSD has detected no increase in rates for other monitored conditions: demyelinating disease, peripheral nervous system disease, seizure, encephalomyelitis, Bell's palsy, other cranial nerve disorders, ataxia, allergic reactions, and myocarditis. VSD will continue H1N1 vaccine safety monitoring throughout the vaccination campaign.
They're not monitoring pregnancy complications.